Comparative Characteristics Of Ferrokinetic Parameters And Their Relationship With Inflammation In Patients With CHF In Advanced And Senile Age
Akhmedova N.Sh , Bukhara State Medical Institute, Uzbekistan Abdullaeva U.K. , Bukhara State Medical Institute, Uzbekistan Musulmanova D.F. , Bukhara State Medical Institute, UzbekistanAbstract
To perform a comparative analysis of anemia of chronic disease (ACD) and iron-deficiency anemia (IDA) in late middle-aged and elderly patients with chronic heart failure (CHF) by ferrokinetic parameters, inflammation indexes, and their associations. Materials and methods. 65 patients with ischemic heart disease were evaluated, including 35 patients with CHF and ACD, 10 patients with CHF and IDA, and 20 patients without CHF, ACD, and IDA (control group, CG). Results. Patients with CHF and IDA had true iron deficiency whereas 54% of patients with CHF and ACD had functional iron deficiency, and 46% of patients had no iron deficiency. Levels of acute phase proteins, ferritin and hepcidin, C-reactive protein (CRP), and interleukin-6 (IL-6) were highly significantly different in patients with CHF and ACD and patients with CHF and IDA; positive and significant correlations were found for levels of IL-6 and ferritin, IL-6 and CRP, and CRP and hepcidin. In patients with CHF and IDA, levels of acute phase proteins, ferritin and hepcidin, CRP, and IL-6 were low and correlations of IL-6 with ferritin, IL-6 with CRP, and CRP with hepcidin were non-significant. Concentrations of erythropoietin were significantly higher in patients with CHF and ACD and patients with CHF and IDA compared to the control group; however, significant differences between them were absent.
Keywords
Chronic heart failure, anemia of chronic disease
References
Lazareva N. V., Oshchepkova E. V., Tereschenko S. N. Comorbidity(heart failure according the register). Kardiologicheskij Vestnik. 2016;XI(4):24-31.
Tang Y-D. Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options. Circulation. 2006;113 (20):2454–61. DOI:10.1161/CIRCULATIONAHA. 105.583666
van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey: Co-morbidities in heart failure. European Journal of Heart Failure. 2014;16 (1):103–11. DOI:10.1002/ejhf. 30
Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ et al. Anemia and Mortality in Heart Failure Patients. Journal of the American College of Cardiology. 2008;52 (10):818–27. DOI:10.1016/j. jacc. 2008.04.061
Anand I. Anemia and Its Relationship to Clinical Outcome in Heart Failure. Circulation. 2004;110 (2):149–54. DOI:10.1161/01. CIR. 0000134279.79571.73
Muzzarelli S, Pfisterer M. Anemia as independent predictor of major events in elderly patients with chronic angina. American Heart Journal. 2006;152 (5):991–6. DOI:10.1016/j. ahj. 2006.06.014
Anand IS. Anemia and Chronic Heart Failure. Journal of the American College of Cardiology. 2008;52 (7):501–11. DOI:10.1016/j. jacc. 2008.04.044
Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. Circulation. 2003;107 (2):223–5.
Rudakova L. E., Belyaeva Yu. B., Fatkabrarova A. M., Kozina L. E. Anemia in chronic heart failure (according to the cardiology Department). Theoretical and applied aspects of modern science. 2014;6-2:128-30.
Article Statistics
Copyright License
Copyright (c) 2021 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.